Frank Biondi - Amgen Insider

Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Independent Director

Mr. Frank J. Biondi, Jr., is an Independent Director of Amgen Inc. Frank J. Biondi, Jr. has served as Senior Managing Director of WaterView Advisors LLC, an investment advisor organization, since 1999. Prior to WaterView Advisors, Mr. Biondi was the Chairman and Chief Executive Officer of Universal Studios, Inc. from 1996 to 1998, the President and Chief Executive Officer of Viacom, Inc. from 1987 to 1996, Executive Vice President of Entertainment Business Sector of The CocaCola Company and Chairman and Chief Executive Officer of CocaCola Television from 1985 to 1987, Chairman and Chief Executive Officer of Time Inc.s subsidiary Home Box Office, Inc. from 1982 to 1984, Vice President of Time Inc. from 1978 to 1984 and Assistant Treasurer of the Childrens Television Workshop from 1974 to 1978
Age: 70  Director Since 2002      
805-447-1000  http://www.amgen.com
Biondi was a director of Cablevision Systems Corporationrationration, a telecommunications, media and entertainment company, since 2005; Seagate Technology plc, a manufacturer of data storage products, since 2005, serving on its Compensation Committee and chairing its Finance Committee; and ViaSat, Inc., a provider of satellite and other wireless networking systems, since April 2015, serving on its Audit and Compensation and Human Resources Committees.

Frank Biondi Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 8.32 % which means that it generated profit of $8.32 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 7.18 % meaning that it created $7.18 on every $100 dollars invested by stockholders.
The company currently holds 35.34 B in liabilities with Debt to Equity (D/E) ratio of 140.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 5.38 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Ronald TaylorAllergan plc
2013
Nancy HutsonEndo International plc
2009
Elaine UllianVertex Pharmaceuticals Incorpor
2011
William OsbornAbbott Laboratories
2013
Joel McCombBio Rad Laboratories Inc
2014
Ron TaylorAllergan plc
2013
Louis DrapeauBio Rad Laboratories Inc
2007
Patrick OSullivanAllergan plc
2013
Christopher CoughlinAllergan plc
2016
Jill SmithEndo International plc
2012
Fred WeissAllergan plc
2013
Douglas IngramEndo International plc
2016
Phebe NovakovicAbbott Laboratories
2010
Catherine KlemaAllergan plc
2016
William YoungVertex Pharmaceuticals Incorpor
2014
Daniel StarksAbbott Laboratories
2017
Alan GarberVertex Pharmaceuticals Incorpor
2017
James BloemAllergan plc
2013
David AltshulerVertex Pharmaceuticals Incorpor
2015
Terrence KearneyVertex Pharmaceuticals Incorpor
2011
Glenn TiltonAbbott Laboratories
2007

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 20800 people.Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Wanda Austin, Director
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators